Insulin-like Growth Factor 2 (IGF-2) Potentiates BMP-9-Induced Osteogenic Differentiation and Bone Formation

Efficient osteogenic differentiation and bone formation from mesenchymal stem cells (MSCs) should have clinical applications in treating nonunion fracture healing. MSCs are adherent bone marrow stromal cells that can self‐renew and differentiate into osteogenic, chondrogenic, adipogenic, and myogenic lineages. We have identified bone morphogenetic protein 9 (BMP‐9) as one of the most osteogenic BMPs. Here we investigate the effect of insulin‐like growth factor 2 (IGF‐2) on BMP‐9‐induced bone formation. We have found that endogenous IGF‐2 expression is low in MSCs. Expression of IGF‐2 can potentiate BMP‐9‐induced early osteogenic marker alkaline phosphatase (ALP) activity and the expression of later markers. IGF‐2 has been shown to augment BMP‐9‐induced ectopic bone formation in the stem cell implantation assay. In perinatal limb explant culture assay, IGF‐2 enhances BMP‐9‐induced endochondral ossification, whereas IGF‐2 itself can promote the expansion of the hypertropic chondrocyte zone of the cultured limb explants. Expression of the IGF antagonists IGFBP3 and IGFBP4 leads to inhibition of the IGF‐2 effect on BMP‐9‐induced ALP activity and matrix mineralization. Mechanistically, IGF‐2 is further shown to enhance the BMP‐9‐induced BMPR‐Smad reporter activity and Smad1/5/8 nuclear translocation. PI3‐kinase (PI3K) inhibitor LY294002 abolishes the IGF‐2 potentiation effect on BMP‐9‐mediated osteogenic signaling and can directly inhibit BMP‐9 activity. These results demonstrate that BMP‐9 crosstalks with IGF‐2 through PI3K/AKT signaling pathway during osteogenic differentiation of MSCs. Taken together, our findings suggest that a combination of BMP‐9 and IGF‐2 may be explored as an effective bone‐regeneration agent to treat large segmental bony defects, nonunion fracture, and/or osteoporotic fracture. © 2010 American Society for Bone and Mineral Research.

[1]  E. Wilson,et al.  Selective Signaling by Akt2 Promotes Bone Morphogenetic Protein 2-Mediated Osteoblast Differentiation , 2009, Molecular and Cellular Biology.

[2]  C. Mandal,et al.  Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. , 2009, Endocrinology.

[3]  T. He,et al.  Retinoic acid signalling induces the differentiation of mouse fetal liver‐derived hepatic progenitor cells , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[4]  T. He,et al.  Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. , 2009, Differentiation; research in biological diversity.

[5]  Fa-Ming Chen,et al.  In vitro cellular responses to scaffolds containing two microencapulated growth factors. , 2009, Biomaterials.

[6]  T. He,et al.  Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells , 2009, Journal of cellular biochemistry.

[7]  T. He,et al.  BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling , 2009, Journal of cellular and molecular medicine.

[8]  C. Pilapil,et al.  Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. , 2009, Tissue engineering. Part A.

[9]  T. He,et al.  A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. , 2009, Stem cells and development.

[10]  P. Rotwein,et al.  Akt promotes BMP2-mediated osteoblast differentiation and bone development , 2009, Journal of Cell Science.

[11]  S. Goto,et al.  IGF2 modulates the microenvironment for osteoclastogenesis. , 2009, Biochemical and biophysical research communications.

[12]  T. He,et al.  Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells* , 2009, Journal of Biological Chemistry.

[13]  A. Montag,et al.  Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects , 2008, Laboratory Investigation.

[14]  P. Rotwein,et al.  Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. , 2008, Molecular endocrinology.

[15]  A. Raucci,et al.  Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways , 2008, Journal of cellular physiology.

[16]  A. Montag,et al.  Regulation of osteogenic differentiation during skeletal development. , 2008, Frontiers in bioscience : a journal and virtual library.

[17]  B. Hallgrímsson,et al.  Inactivation of Pten in Osteo‐Chondroprogenitor Cells Leads to Epiphyseal Growth Plate Abnormalities and Skeletal Overgrowth , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[19]  K. Kinzler,et al.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.

[20]  M. Bouxsein,et al.  Lifelong accumulation of bone in mice lacking Pten in osteoblasts , 2007, Proceedings of the National Academy of Sciences.

[21]  T. He,et al.  Wnt signaling and human diseases: what are the therapeutic implications? , 2007, Laboratory Investigation.

[22]  E. Beutler,et al.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6 , 2006, Proceedings of the National Academy of Sciences.

[23]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[24]  Pinchas Cohen,et al.  The role of the insulin-like growth factor system in prenatal growth. , 2005, Molecular genetics and metabolism.

[25]  J. Wrana,et al.  The disparate role of BMP in stem cell biology , 2005, Oncogene.

[26]  Jiwang Zhang,et al.  BMP signaling and stem cell regulation. , 2005, Developmental biology.

[27]  A. Osyczka,et al.  Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. , 2005, Endocrinology.

[28]  S. Takai,et al.  Possible Involvement of Phosphatidylinositol 3-Kinase/Akt Pathway in Insulin-like Growth Factor-I-induced Alkaline Phosphatase Activity in Osteoblasts , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[29]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[30]  S. Mohan,et al.  Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. , 2005, Endocrinology.

[31]  A. Montag,et al.  Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[32]  S. Morrison,et al.  Diverse mechanisms regulate stem cell self-renewal. , 2004, Current opinion in cell biology.

[33]  J. Szatkowski,et al.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery , 2004, Gene Therapy.

[34]  Wei Jiang,et al.  Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[35]  T. Fujita,et al.  Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling , 2004, The Journal of cell biology.

[36]  Hongwei Cheng,et al.  Transcriptional characterization of bone morphogenetic proteins (BMPs)‐mediated osteogenic signaling , 2003, Journal of cellular biochemistry.

[37]  Di Chen,et al.  E3 Ubiquitin Ligase Smurf1 Mediates Core-binding Factor α1/Runx2 Degradation and Plays A Specific Role in Osteoblast Differentiation* , 2003, Journal of Biological Chemistry.

[38]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[39]  C. Conover,et al.  Transforming Growth Factor‐β Regulation of the Insulin‐Like Growth Factor Binding Protein‐4 Protease System in Cultured Human Osteoblasts , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  T. Clemens,et al.  Paracrine Overexpression of IGFBP‐4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  Mallika Singh,et al.  An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis , 2003, Nature Biotechnology.

[42]  Guang-Quan Zhao,et al.  Consequences of knocking out BMP signaling in the mouse , 2003, Genesis.

[43]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[44]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[45]  A. Celeste,et al.  Requirement of BMP-2-induced Phosphatidylinositol 3-Kinase and Akt Serine/Threonine Kinase in Osteoblast Differentiation and Smad-dependent BMP-2 Gene Transcription* , 2002, The Journal of Biological Chemistry.

[46]  E. Li.  Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.

[47]  Jeffrey L. Wrana,et al.  Signal Transduction by the TGF-β Superfamily , 2002, Science.

[48]  A. Montag,et al.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  J. Wrana,et al.  Signal transduction by the TGF-beta superfamily. , 2002, Science.

[50]  S. Mohan,et al.  Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. , 2001, Endocrinology.

[51]  C. Conover,et al.  Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. , 2000, Endocrinology.

[52]  J. Blusztajn,et al.  Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. , 2000, Science.

[53]  B. Olsen,et al.  Bone development. , 2000, Annual review of cell and developmental biology.

[54]  Luke Hughes-Davies,et al.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity , 2000, Nature Genetics.

[55]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[56]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[57]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[58]  Ian N. M. Day,et al.  Molecules in focus Insulin-like growth factor II (IGF-II) , 1998 .

[59]  I. Day,et al.  Insulin-like growth factor II (IGF-II). , 1998, The international journal of biochemistry & cell biology.

[60]  J. Aubin,et al.  Advances in the osteoblast lineage. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[61]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Ludwig,et al.  Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. , 1997, Genes & development.

[63]  D. Solter,et al.  Roles of the imprinted gene Igf2 and paternal duplication of distal chromosome 7 in the perinatal abnormalities of androgenetic mouse chimeras. , 1997, Development.

[64]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[65]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[66]  V. Rosen,et al.  Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. , 1995, Endocrinology.

[67]  T. Chard.  Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. , 1994, Growth regulation.

[68]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[69]  A. Efstratiadis,et al.  Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.